• news

Celaid advances to Final Round of Acceleration Program "Mirai Cross 2023"

Of the approximately 130 companies that applied for the "Mirai X (mirai cross) 2023 Acceleration Program", 40 startups that passed the first round of document screening participated in a second round of screening and gave presentations on November 28, 2022. As a result of the secondary screening, 30 companies and organizations, including our company, were selected to proceed to the final screening session.
The final judging will be held on January 16, 2023 at RIHGA Royal Hotel Osaka, where the startups that passed the second round will give their presentations.

The event will be streamed live on YouTube and is open to the public. If you would like to watch the event, please fill out the form below.
Application form:

Copyright© セレイドセラピューティクス - 細胞治療(造血幹細胞) , 2024 All Rights Reserved Powered by STINGER.